Laura Peeters

dystrophy. Journal of Neuroengineering and Rehabilitation 2017;14:45. 16. Wadman RI, Wijngaarde CA, Stam M, et al. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4. European Journal of Neurology 2018;25:512-518. 17. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological Reviews 2002;82:291-329. 18. van den Bergen JC, Ginjaar HB, van Essen AJ, et al. Forty-Five Years of Duchenne Muscular Dystrophy in The Netherlands. J Neuromuscul Dis 2014;1:99-109. 19. McDonald CM, Henricson EK, Abresch RT, et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 2018;391:451-461. 20. Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE. Disability and survival in Duchenne muscular dystrophy. Journal of Neurology, Neurosurgery, and Psychiatry 2009;80:320-325. 21. Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 2007;1772:229-237. 22. Prior TW, Snyder PJ, Rink BD, et al. Newborn and carrier screening for spinal muscular atrophy. American Journal of Medical Genetics Part A 2010;152A:1608-1616. 23. Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle & Nerve 2015;51:157-167. 24. Wadman RI, Stam M, Gijzen M, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4. Journal of Neurology, Neurosurgery, and Psychiatry 2017;88:365-367. 25. Muscular Dystrophy Association. Duchenne muscular dystrophy & spinal muscular atrophy [online]. Available at: https://www.mda.org/disease . Accessed 25-02-2019. 26. Vuillerot C, Payan C, Iwaz J, Ecochard R, Berard C, Group MFMSMAS. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Archives of Physical Medicine and Rehabilitation 2013;94:1555-1561. 27. Mercuri E, Darras BT, Chiriboga CA, et al. Nusinersen versus Sham Control in Later- Onset Spinal Muscular Atrophy. New England Journal of Medicine 2018;378:625-635. 28. Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London: Her Majesty’s Stationary Office1976. 29. Wikholm JB, Bohannon RW. Hand-held Dynamometer Measurements: Tester Strength Makes a Difference. Journal of Orthopaedic and Sports Physical Therapy 1991;13:191-198. 30. Wu G, Siegler S, Allard P, et al. ISB recommendation on definitions of joint coordinate system of various joints for the reporting of human joint motion--part I: ankle, hip, and spine. International Society of Biomechanics. Journal of Biomechanics 2002;35:543-548. 31. Wu G, van der Helm FC, Veeger HE, et al. ISB recommendation on definitions of joint coordinate systems of various joints for the reporting of human joint motion--Part II: shoulder, elbow, wrist and hand. Journal of Biomechanics 2005;38:981-992.